Amexdrug Corporation
AXRX
Rank in Stocks
#34157
Amexdrug Corporation, founded in 1963 and headquartered in Commerce,... Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale. The company's operations are divided into two main divisions: Distribution and Health and Beauty Products. Its extensive distribution network encompasses a wide range of items, including prescription and over-the-counter medications, various non-drug products, and health and beauty essentials. Amexdrug also provides services in private manufacturing and labeling. Specific product lines manufactured and sold by the company, often under its Sponix brand, include facial and body creams, arthritic pain relief treatments, and hair and nail care products. These goods are supplied to a diverse clientele such as pharmacies, beauty salons, beauty supply outlets, and other retail establishments. Within the state of California, Amexdrug's distribution channels primarily target independent pharmacies, extending secondarily to smaller pharmacy chains, alternative care facilities, and various wholesalers and retailers. The company adopted the name Amexdrug Corporation in April 2000, changing from its previous identity as Harlyn Products, Inc., to reflect its strategic focus on pharmaceutical sales.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$33.88K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Amexdrug Corporation (AXRX)
Category
Healthcare
Operating Margin for Amexdrug Corporation (AXRX)
Operating Margin as of November 2026 TTM: 5.29%
According to Amexdrug Corporation's latest financial reports, its current operating margin (TTM) is 5.29%. At the end of 2025 the company had an operating margin of 4.71%.
Operating Margin history for Amexdrug Corporation from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 5.29% | 12.31% |
| 2025 | 4.71% | 33.43% |
| 2024 | 3.53% | 18.06% |
| 2023 | 2.99% | 5.65% |
| 2021 | 2.83% | -42.71% |
| 2020 | 4.94% | 36.09% |
| 2019 | 3.63% | 53.16% |
| 2018 | 2.37% | 15.05% |
| 2017 | 2.06% | 31.21% |
| 2016 | 1.57% | -17.37% |
| 2015 | 1.90% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -96.33% |
DE
|
|
| 19.68% | -96.28% |
DE
|
|
| 13.26% | -97.49% |
JP
|
|
| 17.08% | -96.77% |
CH
|
|
| 14.92% | -97.18% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Amexdrug Corporation's operating margin
What is Amexdrug Corporation's operating margin?
Amexdrug Corporation's operating margin is 5.29%, as of Nov 2026.
What was Amexdrug Corporation's operating margin in 2025?
In 2025, Amexdrug Corporation's operating margin was 4.71%, compared with 3.53% in 2024.
How has Amexdrug Corporation's operating margin changed since 2020?
From 2020 to 2025, Amexdrug Corporation's operating margin was highest in 2020 (4.94%) and lowest in 2021 (2.83%).
How does Amexdrug Corporation's operating margin compare with similar companies?
Amexdrug Corporation's operating margin (5.29%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.